Skandinaviska Enskilda Banken Ab (Publ) Codexis, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$8.35 - $21.89 $251,819 - $660,158	-30,158 Reduced 48.35%	32,217 $337,000
Q1 2022 May 11, 2022	SELL	$16.97 - $31.93 $327,673 - $616,536	-19,309 Reduced 23.64%	62,375 $1.29 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $41.78 $601,245 - $980,869	23,477 Added 40.33%	81,684 $2.58 Million
Q3 2021 Nov 10, 2021	SELL	$19.65 - $27.99 $72,606 - $103,423	-3,695 Reduced 5.97%	58,207 $1.35 Million
Q2 2021 Aug 10, 2021	BUY	$17.48 - $25.46 $30,397 - $44,274	1,739 Added 2.89%	61,902 $1.4 Million
Q1 2021 May 14, 2021	SELL	$18.08 - $28.8 $105,984 - $168,825	-5,862 Reduced 8.88%	60,163 $1.38 Million
Q4 2020 Feb 11, 2021	BUY	$11.7 - $23.41 $150,029 - $300,186	12,823 Added 24.1%	66,025 $1.44 Million
Q3 2020 Nov 12, 2020	BUY	$11.21 - $13.82 $582,931 - $718,653	52,001 Added 4329.81%	53,202 $625,000
Q2 2020 Aug 13, 2020	BUY	$9.8 - $12.77 $11,769 - $15,336	1,201 New	1,201 $14,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.